MedPath

Clinicopathological MRI and CSF correlates of iron accumulation, neurodegeneration and neuroinflammation in Huntington*s disease.

Recruiting
Conditions
Huntington's disease
10029299
10029305
Registration Number
NL-OMON54707
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Male and female individuals with an age of 18 years and older; Ability to
undergo MRI scanning; For individuals diagnosed with HD, a positive genetic
test with a CAG repeat expansion of > 36 in the HTT gene is required; For
pre-manifest participants a positive genetic test with a CAG repeat expansion
of >= 40 in the HTT gene is required.

Exclusion Criteria

Contra-indications to MRI scanning and lumbar puncture; Pregnancy; Severe
chorea; Inability to understand the information about the protocol; Severe
physical restrictions.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter are the striatal and cortical QSM measures, in<br /><br>combination with CSF markers for iron, neurodegeneration and neuroinflammation,<br /><br>in een Huntington populatie, in vergelijking tot gezonde controle deelnemers. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Outcome measurement of clinical (neurologisch and psychological) and genetic<br /><br>tests and their correlation with iron accumulation.<br /><br>- Neuroinflammation metabolites, levels and characteristics, as measured with<br /><br>(DW-)MRS iin combinaties with QSM measures en neuroinflammation - biomarkers in<br /><br>CSF, in a Huntington's Disease population, as compared with healthy controls. </p><br>
© Copyright 2025. All Rights Reserved by MedPath